Ascelia Pharma AB (OSTO:ACE) Accounts Payable : kr1.53 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Accounts Payable?

Ascelia Pharma AB's Accounts Payable for the quarter that ended in Dec. 2023 was kr1.53 Mil.

Ascelia Pharma AB's quarterly Accounts Payable declined from Jun. 2023 (kr6.50 Mil) to Sep. 2023 (kr4.62 Mil) and declined from Sep. 2023 (kr4.62 Mil) to Dec. 2023 (kr1.53 Mil).

Ascelia Pharma AB's annual Accounts Payable increased from Dec. 2021 (kr6.15 Mil) to Dec. 2022 (kr15.88 Mil) but then declined from Dec. 2022 (kr15.88 Mil) to Dec. 2023 (kr1.53 Mil).

Ascelia Pharma AB Accounts Payable Historical Data

The historical data trend for Ascelia Pharma AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Accounts Payable Chart

Ascelia Pharma AB Annual Data

Trend

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

4.27

3.88

6.15

15.88

1.53

Ascelia Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															15.88	8.10	6.50	4.62	1.53

Ascelia Pharma AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Ascelia Pharma AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

7ZA:Germany

Address

Hyllie Boulevard 34, Malmo, SWE, SE-215 32

Website

https://www.ascelia.com

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines